Product Type
Condition
Binding
Collectible Attributes
Free Shipping
Seller Location
Seller Rating
Published by Springer, 2018
ISBN 10: 3319753096ISBN 13: 9783319753096
Seller: Antique Emporium, Eau Claire, WI, U.S.A.
Book First Edition
Hardcover. Condition: Very Good. No Jacket. 1st Edition. Hardcover book has a small tear on back by spine else like new.
Published by Springer, 2018
ISBN 10: 3319753096ISBN 13: 9783319753096
Seller: SpringBooks, Berlin, Germany
Book First Edition
Hardcover. Condition: Very Good. 1. Auflage. Unread, little shelfwear.
Published by Springer, 2018
ISBN 10: 3319753096ISBN 13: 9783319753096
Seller: Brook Bookstore, Milano, MI, Italy
Book
Condition: new.
Published by Springer International Publishing AG, Cham, 2018
ISBN 10: 3319753096ISBN 13: 9783319753096
Seller: CitiRetail, Stevenage, United Kingdom
Book First Edition
Hardcover. Condition: new. Hardcover. This book sheds new light on the management of patients with borderline cardiovascular risk factors in order to prevent their progression to end organ damage. The book stimulates discussion of this poorly understood condition and lays the groundwork for developing recommendations and guidelines.While the diagnostic and therapeutic approach to full-blown diabetes, hypertension, dyslipidemia and obesity is well defined, there is still a lack of clear understanding and guidelines as far as patients with borderline conditions especially when multiple are concerned. Moreover, end-organ damage depends on several factors, including genetic factors, making it difficult to predict its extent. As such, the gradual transition from a healthy subject to one with functional hemodynamic changes, and then one with structurally asymptomatic changes and lastly to overt disease needs further investigation.In order to address these knowledge gaps, the book covers a broad variety of topics, making it a valuable tool for identifying which asymptomatic subjects could profit from being appropriately screened and at what stage. Furthermore it offers insights into better treating these patients to prevent their progression to overt disease. The book appeals to cardiologists, primary care physicians and all those healthcare professional looking to optimize the management of these complex and often undiagnosed cases. This book sheds new light on the management of patients with borderline cardiovascular risk factors in order to prevent their progression to end organ damage. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.
Published by Springer, 2018
ISBN 10: 3319753096ISBN 13: 9783319753096
Seller: Revaluation Books, Exeter, United Kingdom
Book
Hardcover. Condition: Brand New. 689 pages. 9.25x6.10x1.46 inches. In Stock.
Published by Springer International Publishing, 2018
ISBN 10: 3319753096ISBN 13: 9783319753096
Seller: moluna, Greven, Germany
Book
Gebunden. Condition: New.
Published by Springer International Publishing Dez 2018, 2018
ISBN 10: 3319753096ISBN 13: 9783319753096
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Book Print on Demand
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book sheds new light on the management of patients with borderline cardiovascular risk factors in order to prevent their progression to end organ damage. The book stimulates discussion of this poorly understood condition and lays the groundwork for developing recommendations and guidelines.While the diagnostic and therapeutic approach to full-blown diabetes, hypertension, dyslipidemia and obesity is well defined, there is still a lack of clear understanding and guidelines as far as patients with borderline conditions - especially when multiple - are concerned. Moreover, end-organ damage depends on several factors, including genetic factors, making it difficult to predict its extent. As such, the gradual transition from a healthy subject to one with functional hemodynamic changes, and then one with structurally asymptomatic changes and lastly to overt disease needs further investigation.In order to address these knowledge gaps, the book covers a broad variety of topics, making it a valuable tool for identifying which asymptomatic subjects could profit from being appropriately screened and at what stage. Furthermore it offers insights into better treating these patients to prevent their progression to overt disease. The book appeals to cardiologists, primary care physicians and all those healthcare professional looking to optimize the management of these complex and often undiagnosed cases. 704 pp. Englisch.
Published by Springer International Publishing, 2018
ISBN 10: 3319753096ISBN 13: 9783319753096
Seller: AHA-BUCH GmbH, Einbeck, Germany
Book
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book sheds new light on the management of patients with borderline cardiovascular risk factors in order to prevent their progression to end organ damage. The book stimulates discussion of this poorly understood condition and lays the groundwork for developing recommendations and guidelines.While the diagnostic and therapeutic approach to full-blown diabetes, hypertension, dyslipidemia and obesity is well defined, there is still a lack of clear understanding and guidelines as far as patients with borderline conditions - especially when multiple - are concerned. Moreover, end-organ damage depends on several factors, including genetic factors, making it difficult to predict its extent. As such, the gradual transition from a healthy subject to one with functional hemodynamic changes, and then one with structurally asymptomatic changes and lastly to overt disease needs further investigation.In order to address these knowledge gaps, the book covers a broad variety of topics, making it a valuable tool for identifying which asymptomatic subjects could profit from being appropriately screened and at what stage. Furthermore it offers insights into better treating these patients to prevent their progression to overt disease. The book appeals to cardiologists, primary care physicians and all those healthcare professional looking to optimize the management of these complex and often undiagnosed cases.
Published by Springer International Publishing AG, Cham, 2018
ISBN 10: 3319753096ISBN 13: 9783319753096
Seller: AussieBookSeller, Truganina, VIC, Australia
Book First Edition
Hardcover. Condition: new. Hardcover. This book sheds new light on the management of patients with borderline cardiovascular risk factors in order to prevent their progression to end organ damage. The book stimulates discussion of this poorly understood condition and lays the groundwork for developing recommendations and guidelines.While the diagnostic and therapeutic approach to full-blown diabetes, hypertension, dyslipidemia and obesity is well defined, there is still a lack of clear understanding and guidelines as far as patients with borderline conditions especially when multiple are concerned. Moreover, end-organ damage depends on several factors, including genetic factors, making it difficult to predict its extent. As such, the gradual transition from a healthy subject to one with functional hemodynamic changes, and then one with structurally asymptomatic changes and lastly to overt disease needs further investigation.In order to address these knowledge gaps, the book covers a broad variety of topics, making it a valuable tool for identifying which asymptomatic subjects could profit from being appropriately screened and at what stage. Furthermore it offers insights into better treating these patients to prevent their progression to overt disease. The book appeals to cardiologists, primary care physicians and all those healthcare professional looking to optimize the management of these complex and often undiagnosed cases. This book sheds new light on the management of patients with borderline cardiovascular risk factors in order to prevent their progression to end organ damage. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.